Target intelligence / Profile preview

T-cell receptor-CD3 complex (CD3 delta, gamma, and zeta subunits) (TCR-CD3 complex)

Target
TCR-CD3 complex
Molecular classification
Receptor, Multi-subunit protein complex, Immunoglobulin superfamily, Signal transducer
01

Overview

The TCR-CD3 complex is a critical multi-subunit signaling apparatus located on the surface of T lymphocytes, essential for the adaptive immune response. It consists of the antigen-binding T-cell receptor (TCR) heterodimer associated with four invariant CD3 chains: the CD3 gamma-epsilon and CD3 delta-epsilon heterodimers, and the CD3 zeta-zeta homodimer (StatPearls, NBK554481). While the TCR recognizes specific peptide-MHC complexes, the CD3 delta, gamma, and zeta chains are responsible for transmitting the activation signal into the cell via their cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) (UniProt, P20963; UniProt, P04234). The CD3 zeta chain, in particular, is a primary driver of signal amplification and is frequently utilized as the signaling domain in Chimeric Antigen Receptor (CAR) T-cell therapies (PubMed, 29983348). This complex is a major therapeutic target for bispecific antibodies that redirect T-cell killing toward tumor cells and for monoclonal antibodies designed to induce immune tolerance in autoimmune conditions like Type 1 diabetes (PubMed, 33033267). Genetic mutations in the CD3 delta, gamma, or zeta subunits can lead to severe combined immunodeficiency (SCID) due to the failure of T-cell maturation and signaling (NCBI Gene, 915).

Other names
CD3 complexCD3D/CD3G/CD247 complexT3 complexT-cell surface glycoprotein CD3CD3 delta (CD3D)CD3 gamma (CD3G)CD3 zeta (CD247)T-cell receptor-associated CD3 complex
02

Mechanism of action

T-cell activation via ITAM phosphorylation, redirection of T-cell cytotoxicity through bispecific engagement, and immunomodulation via TCR-CD3 complex internalization or T-cell depletion.

03

Biological functions

Signal transductionImmune responseT-cell activationT-cell developmentAntigen recognitionThymocyte selection
04

Disease associations

CancerAutoimmune diseaseGraft-versus-host diseaseSevere combined immunodeficiency (SCID)Type 1 diabetesInflammation
05

Safety considerations

Cytokine release syndrome (CRS)Immune effector cell-associated neurotoxicity syndrome (ICANS)LymphopeniaInfusion-related reactionsIncreased risk of opportunistic infections
06

Interacting drugs

Muromonab-CD3

9 more in the full profile.

07

Biomarkers

CD3 expression (IHC/Flow cytometry)Absolute lymphocyte countSerum IL-6 levelsInterferon-gamma levelsT-cell receptor repertoire diversity

Beyond the preview

Go deeper on T-cell receptor-CD3 complex (CD3 delta, gamma, and zeta subunits) (TCR-CD3 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor-CD3 complex (CD3 delta, gamma, and zeta subunits) (TCR-CD3 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call